Although most blood glucose meters are theoretically able to upload test results to a computer, the reality can be a frustrating, time-consuming process. Different...

During our recent trip to Portugal for the 47th Annual Meeting of EASD, we had the chance to see the once-weekly GLP-1 drug Bydureon for the first time since its...

Valeritas’ V-Go Disposable Insulin Delivery Device. In late July, Valeritas announced it had received CE Mark approval for its V-Go disposable insulin delivery device,...

While the rest of America was watching the Super Bowl, we were taking in the countryside in Montpellier, France, at first annual European Diabetes Technology and...

Larry Soler and Dr. James Gavin discuss Partnership for a Healthier America's efforts to fight childhood obesity.

Kerri Morrone Sparling advocates for unity in the diabetes community.

On January 27, the Food and Drug Administration (FDA) granted approval to Bydureon, a new drug for type 2 diabetes that is injected once a week. Approved last year in...

The diaTribe team had an outstanding evening in San Francisco for World Diabetes Day on November 14, which included blue hula hooping in Union Square. (For those who...

In welcome news, the pharmaceutical companies Amylin, Eli Lilly, and Alkermes announced in early July that Bydureon , a drug for people with type 2 diabetes meant to be...

In exciting news, Vivus announced that it intends to resubmit its weight-loss drug Qnexa to the FDA for review by the end of October. As a reminder, in October 2010, the...

We always love attending the ADA Postgrad meeting – an update for doctors and nurses on new practices in diabetes.

World Diabetes Day 2007 - Beautiful Landmarks for an Unrecognized Epidemic (B.L.U.E)

Kerri Morrone Sparling reflects on the true meaning of ‘need’ in the global diabetes community…

Earlier this month, the FDA chose not to approve Bristol-Myers Squibb/AstraZeneca’s dapagliflozin, a member of a class of drugs that causes users to excrete excess...

Nine year-old Boaz Alkalay offers a rare glimpse of diabetes through the eyes of a child.

In late March, the International Diabetes Federation (IDF) released a "position statement" recommending the consideration of bariatric surgery to treat type 2 diabetes...

Dr. Lawrence Soler writes a letter of concern to the New York Times .

Recently, we learned that the Japan-based pharmaceutical company Takeda has submitted its type 2 diabetes therapy alogliptin for approval in the US. The therapy has been...

JDRF is offering a $100,000 prize for innovative ideas on how to develop a glucose-responseive insulin Earlier this month, JDRF announced that it would award a $100,000...

In October 2010, Biocon, an Indian pharmaceutical company, and Pfizer partnered to develop and market biosimilar insulin analogs (see NewNowNext in diaTribe #26). A...